OpenAlex
PricingAboutJobs
Log inGet started
Work

Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis

HTML

Year: 2012
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.2012.703178
Authors: Petra Dunkel, Christina LL Chai, Beáta Sperlágh, Paul B Huleatt, Péter Mátyus
Institutions: Semmelweis University, National University of Singapore, Institute of Chemical and Engineering Sciences, HUN-REN Institute of Experimental Medicine, Hungarian Academy of Sciences
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: neuroprotective agents, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, disease-modifying therapy, drug development, drug repurposing, network pharmacology, clinical trials
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2031785947
FWCI: 0.845
Cites: 192
Cited by: 120
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security